Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.1487926032435424e-12,86.55118110236221,2268.350990258535,"['RPL41', 'RPL3', 'RPS7', 'RPL35A', 'RPSA', 'RPL10A', 'RPS26', 'RPL7A', 'RPS15A', 'RPS27', 'RPL18A', 'RPL26', 'RPL15', 'FAU', 'RPS27A', 'RPS21']",3.5679616387894463e-10,0,0,16
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.00014272941367965352,30.087591240875913,266.4123798587588,"['UQCRQ', 'NDUFA4', 'UQCR11', 'SLC25A5', 'COX7A1', 'COX7C']",0.006137364788225101,0,0,6
3,Nonalcoholic fatty liver disease WP4396,0.0006993155543051537,8.801470588235293,63.94627905548071,"['UQCRQ', 'NDUFA4', 'NDUFB11', 'CYCS', 'UQCR11', 'COX7C', 'COX7A1']",0.01820269293545088,0,0,7
4,Mitochondrial CIV Assembly WP4922,0.0008466368807186456,inf,inf,"['PET100', 'NDUFA4', 'COX14', 'COX7C']",0.01820269293545088,0,0,4
5,Pyrimidine metabolism WP4022,0.01748936301219531,14.721428571428572,59.56529091795319,"['POLE3', 'POLR2I', 'POLR2K']",0.3008170438097593,0,0,3
6,Eukaryotic Transcription Initiation WP405,0.02944033123084482,inf,inf,"['POLR2I', 'POLR2K']",0.3164835607315818,0,0,2
7,Computational Model of Aerobic Glycolysis WP4629,0.02944033123084482,inf,inf,"['TPI1', 'ALDOA']",0.3164835607315818,0,0,2
8,Mitochondrial complex III assembly WP4921,0.02944033123084482,inf,inf,"['UQCRQ', 'UQCR11']",0.3164835607315818,0,0,2
9,Sleep regulation WP3591,0.07830646764548348,9.74468085106383,24.82092097831126,"['CRH', 'HCRTR1']",0.5106822209403395,0,0,2
10,Cori Cycle WP1946,0.07830646764548348,9.74468085106383,24.82092097831126,"['TPI1', 'ALDOA']",0.5106822209403395,0,0,2
11,Alzheimer's disease WP2059,0.1391236195331639,4.865248226950355,9.596178587681177,"['ATP5MD', 'CYCS']",0.5106822209403395,0,0,2
12,TGF-beta Signaling Pathway WP366,0.1391236195331639,4.865248226950355,9.596178587681177,"['PARD6A', 'CITED1']",0.5106822209403395,0,0,2
13,Selenium Micronutrient Network WP15,0.17072182897888008,2.171063149480416,3.83783126897276,"['SELENOM', 'SELENOW', 'SEPHS2', 'SELENOH']",0.5106822209403395,0,0,4
14,DNA Mismatch Repair WP531,0.17208157500119214,inf,inf,['POLE3'],0.5106822209403395,0,0,1
15,Serotonin and anxiety WP3947,0.17208157500119214,inf,inf,['CRH'],0.5106822209403395,0,0,1
16,Serotonin and anxiety-related events WP3944,0.17208157500119214,inf,inf,['CRH'],0.5106822209403395,0,0,1
17,Nucleotide Excision Repair WP4753,0.17208157500119214,inf,inf,['POLE3'],0.5106822209403395,0,0,1
18,Nucleotide metabolism WP404,0.17208157500119214,inf,inf,['OAZ1'],0.5106822209403395,0,0,1
19,Fas ligand pathway and stress induction of heat shock proteins WP314,0.17208157500119214,inf,inf,['CYCS'],0.5106822209403395,0,0,1
20,Fatty acid beta-oxidation WP143,0.17208157500119214,inf,inf,['TPI1'],0.5106822209403395,0,0,1
21,GABA receptor Signaling WP4159,0.17208157500119214,inf,inf,['SLC32A1'],0.5106822209403395,0,0,1
22,Type 2 papillary renal cell carcinoma WP4241,0.17208157500119214,inf,inf,['ELOB'],0.5106822209403395,0,0,1
23,Mitochondrial CII Assembly WP4920,0.17208157500119214,inf,inf,['SDHAF1'],0.5106822209403395,0,0,1
24,Mitochondrial complex I assembly model OXPHOS system WP4324,0.17208157500119214,inf,inf,['NDUFB11'],0.5106822209403395,0,0,1
25,MTHFR deficiency WP4288,0.17208157500119214,inf,inf,['CYCS'],0.5106822209403395,0,0,1
26,HIF1A and PPARG regulation of glycolysis WP2456,0.17208157500119214,inf,inf,['TPI1'],0.5106822209403395,0,0,1
27,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.17208157500119214,inf,inf,['ELOB'],0.5106822209403395,0,0,1
28,Nanomaterial induced apoptosis WP2507,0.17208157500119214,inf,inf,['CYCS'],0.5106822209403395,0,0,1
29,Pathways in clear cell renal cell carcinoma WP4018,0.2063877592946615,3.2387706855791962,5.110775454942165,"['TPI1', 'ALDOA']",0.5106822209403395,0,0,2
30,Glycolysis and Gluconeogenesis WP534,0.2063877592946615,3.2387706855791962,5.110775454942165,"['TPI1', 'ALDOA']",0.5106822209403395,0,0,2
31,VEGFA-VEGFR2 Signaling Pathway WP3888,0.28116477424980685,1.4627737226277373,1.8559883577619718,"['RPL18A', 'CYCS', 'RPL26', 'RPL10A', 'ALDOA', 'TMSB10']",0.5106822209403395,0,0,6
32,Circadian rhythm related genes WP3594,0.29009505501681576,1.8214285714285714,2.2541027972573597,"['CRH', 'RPS27A', 'HCRTR1']",0.5106822209403395,0,0,3
33,Nephrogenesis WP5052,0.31472276406788363,4.838028169014085,5.5930660449671885,['PAX2'],0.5106822209403395,0,0,1
34,DNA Repair Pathways Full Network WP4946,0.31472276406788363,4.838028169014085,5.5930660449671885,['POLE3'],0.5106822209403395,0,0,1
35,Nephrotic syndrome WP4758,0.31472276406788363,4.838028169014085,5.5930660449671885,['PAX2'],0.5106822209403395,0,0,1
36,Dual hijack model of Vif in HIV infection WP3300,0.31472276406788363,4.838028169014085,5.5930660449671885,['ELOB'],0.5106822209403395,0,0,1
37,Non-small cell lung cancer WP4255,0.31472276406788363,4.838028169014085,5.5930660449671885,['CYCS'],0.5106822209403395,0,0,1
38,AGE/RAGE pathway WP2324,0.31472276406788363,4.838028169014085,5.5930660449671885,['CYCS'],0.5106822209403395,0,0,1
39,Apoptosis Modulation by HSP70 WP384,0.31472276406788363,4.838028169014085,5.5930660449671885,['CYCS'],0.5106822209403395,0,0,1
40,Synaptic Vesicle Pathway WP2267,0.31472276406788363,4.838028169014085,5.5930660449671885,['SLC32A1'],0.5106822209403395,0,0,1
41,Base Excision Repair WP4752,0.31472276406788363,4.838028169014085,5.5930660449671885,['POLE3'],0.5106822209403395,0,0,1
42,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.31472276406788363,4.838028169014085,5.5930660449671885,['H2AFZ'],0.5106822209403395,0,0,1
43,Parkinson's disease pathway WP2371,0.31472276406788363,4.838028169014085,5.5930660449671885,['CYCS'],0.5106822209403395,0,0,1
44,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.31472276406788363,4.838028169014085,5.5930660449671885,['SST'],0.5106822209403395,0,0,1
45,MECP2 and Associated Rett Syndrome WP3584,0.31472276406788363,4.838028169014085,5.5930660449671885,['SST'],0.5106822209403395,0,0,1
46,GDNF/RET signaling axis WP4830,0.31472276406788363,4.838028169014085,5.5930660449671885,['PAX2'],0.5106822209403395,0,0,1
47,Genotoxicity pathway WP4286,0.31472276406788363,4.838028169014085,5.5930660449671885,['RPS27'],0.5106822209403395,0,0,1
48,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.31472276406788363,4.838028169014085,5.5930660449671885,['PAX2'],0.5106822209403395,0,0,1
49,Proteasome Degradation WP183,0.31472276406788363,4.838028169014085,5.5930660449671885,['H2AFZ'],0.5106822209403395,0,0,1
50,Vitamin D-sensitive calcium signaling in depression WP4698,0.31472276406788363,4.838028169014085,5.5930660449671885,['PVALB'],0.5106822209403395,0,0,1
51,Modulators of TCR signaling and T cell activation WP5072,0.31472276406788363,4.838028169014085,5.5930660449671885,['ELOB'],0.5106822209403395,0,0,1
52,Regulation of Microtubule Cytoskeleton WP2038,0.31472276406788363,4.838028169014085,5.5930660449671885,['PARD6A'],0.5106822209403395,0,0,1
53,Retinoblastoma gene in cancer WP2446,0.31472276406788363,4.838028169014085,5.5930660449671885,['H2AFZ'],0.5106822209403395,0,0,1
54,ID signaling pathway WP53,0.4329308547537025,2.415492957746479,2.022195757851917,['PAX2'],0.572800823212591,0,0,1
55,16p11.2 proximal deletion syndrome WP4949,0.4329308547537025,2.415492957746479,2.022195757851917,['ALDOA'],0.572800823212591,0,0,1
56,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4329308547537025,2.415492957746479,2.022195757851917,['CYCS'],0.572800823212591,0,0,1
57,Small cell lung cancer WP4658,0.4329308547537025,2.415492957746479,2.022195757851917,['CYCS'],0.572800823212591,0,0,1
58,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4329308547537025,2.415492957746479,2.022195757851917,['BEX3'],0.572800823212591,0,0,1
59,Oxidative phosphorylation WP623,0.4329308547537025,2.415492957746479,2.022195757851917,['NDUFA4'],0.572800823212591,0,0,1
60,Genes controlling nephrogenesis WP4823,0.4329308547537025,2.415492957746479,2.022195757851917,['PAX2'],0.572800823212591,0,0,1
61,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4329308547537025,2.415492957746479,2.022195757851917,['CYCS'],0.572800823212591,0,0,1
62,Ciliary landscape WP4352,0.4329308547537025,2.415492957746479,2.022195757851917,['COPS7A'],0.572800823212591,0,0,1
63,miRNA regulation of DNA damage response WP1530,0.4329308547537025,2.415492957746479,2.022195757851917,['CYCS'],0.572800823212591,0,0,1
64,Development of ureteric collection system WP5053,0.4329308547537025,2.415492957746479,2.022195757851917,['PAX2'],0.572800823212591,0,0,1
65,DNA damage response WP707,0.4329308547537025,2.415492957746479,2.022195757851917,['CYCS'],0.572800823212591,0,0,1
66,Acute viral myocarditis WP4298,0.5308665379651676,1.607981220657277,1.0182454735457875,['CYCS'],0.6672129402845338,0,0,1
67,Cardiac Progenitor Differentiation WP2406,0.5308665379651676,1.607981220657277,1.0182454735457875,['MESP1'],0.6672129402845338,0,0,1
68,Cytosolic DNA-sensing pathway WP4655,0.5308665379651676,1.607981220657277,1.0182454735457875,['POLR2K'],0.6672129402845338,0,0,1
69,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5353220102282887,1.2056737588652482,0.7534096470076553,"['SST', 'ALDOA']",0.6672129402845338,0,0,2
70,Ectoderm Differentiation WP2858,0.6119861681713653,1.204225352112676,0.5913295578567621,['LY6E'],0.7017441395031656,0,0,1
71,Integrated breast cancer pathway WP1984,0.6119861681713653,1.204225352112676,0.5913295578567621,['FAU'],0.7017441395031656,0,0,1
72,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6119861681713653,1.204225352112676,0.5913295578567621,['PFN2'],0.7017441395031656,0,0,1
73,Oxidative Damage WP3941,0.6119861681713653,1.204225352112676,0.5913295578567621,['CYCS'],0.7017441395031656,0,0,1
74,Corticotropin-releasing hormone signaling pathway WP2355,0.6119861681713653,1.204225352112676,0.5913295578567621,['CRH'],0.7017441395031656,0,0,1
75,Hippo-Merlin Signaling Dysregulation WP4541,0.6119861681713653,1.204225352112676,0.5913295578567621,['CDH17'],0.7017441395031656,0,0,1
76,Endoderm differentiation WP2853,0.6791602801704647,0.9619718309859155,0.3721850986823129,['DUSP4'],0.748817744803333,0,0,1
77,Apoptosis WP254,0.6791602801704647,0.9619718309859155,0.3721850986823129,['CYCS'],0.748817744803333,0,0,1
78,Pathways Regulating Hippo Signaling WP4540,0.6791602801704647,0.9619718309859155,0.3721850986823129,['CDH17'],0.748817744803333,0,0,1
79,Myometrial relaxation and contraction pathways WP289,0.734772288874516,0.8004694835680751,0.2467004033792896,['CRH'],0.7998786942178275,0,0,1
80,IL-18 signaling pathway WP4754,0.7602854945871822,0.7364975450081833,0.20184544919919387,"['NRN1', 'CYCS']",0.8173069066812209,0,0,2
81,Hepatitis B infection WP4666,0.7808006605659903,0.6851106639839034,0.1695206297290989,['CYCS'],0.8289982322058663,0,0,1
82,Peptide GPCRs WP24,0.8188873062071212,0.5985915492957746,0.11960386146275041,['HCRTR1'],0.8588330284611272,0,0,1
83,MAPK Signaling Pathway WP382,0.8764521888823795,0.47746478873239434,0.06296477323067476,['DUSP4'],0.9081311836612607,0,0,1
84,Apoptosis Modulation and Signaling WP1772,0.9158071179303295,0.3967136150234742,0.03489076663379883,['CYCS'],0.9265813193177451,0,0,1
85,Complement system WP2806,0.9158071179303295,0.3967136150234742,0.03489076663379883,['FKBP2'],0.9265813193177451,0,0,1
86,"GPCRs, Class A Rhodopsin-like WP455",0.989973101074577,0.20361298224127372,0.002051911224175176,['HCRTR1'],0.989973101074577,0,0,1
